Hutchison China Meditech Share Price (HCM)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Hutchison China Meditech	LSE:HCM	London	Ordinary Share	KYG4672N1016	ORD USD1

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+30.00p	+0.62%	4,850.00p	7,096	16:35:26

Bid Price		Offer Price	High Price	Low Price	Open Price
4,850.00p		4,880.00p	4,865.00p	4,820.00p	4,820.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	178.58	-39.64	-31.84		3,226.8

Related Shares
AstraZeneca (AZN), GlaxoSmithKline (GSK), Venn Life (VENN), Port Erin (PEBI)

Hutchison China Meditech (HCM) Latest News

Hutchison China Meditech News

Date	Time	Source	Headline
31/10/2018	07:00	UKREG	Hutchison China Meditech Limited Total Voting Rights
22/10/2018	09:05	UKREG	Hutchison China Meditech Limited Grant of Share Options under Share Option..
18/10/2018	09:09	ALNC	Hutchison China Meditech Starts Phase I Study For Leukemia In China
18/10/2018	06:21	ALNCF	Alliance News Flash Headline
18/10/2018	06:01	RNSNON	Hutchison China Meditech Limited Chi-Med Initiates a Ph I Trial of HMPL-523..
05/10/2018	06:00	UKREG	Hutchison China Meditech Limited Appointment of HSBC Bank plc as Broker in..
05/9/2018	07:28	ALNC	Hutchison Gains Fruquintinib Capsules Approval As Cancer Drug In China
05/9/2018	06:01	UKREG	Hutchison China Meditech Limited Fruquintinib Approved for CRC in China
31/8/2018	06:00	UKREG	Hutchison China Meditech Limited Total Voting Rights
17/8/2018	16:03	ALNC	TAKING AIM: Edison Praises New Hutchison China Drug Trials

More Hutchison China Meditech News

Hutchison China Meditech Takeover Rumours

Hutchison China Meditech (HCM) Share Charts

1 Year Hutchison China Meditech Chart

1 Month Hutchison China Meditech Chart

Intraday Hutchison China Meditech Chart

Hutchison China Meditech (HCM) Discussions and Chat

Hutchison China Meditech Forums and Chat

Date	Time	Title	Posts
12/11/2018	15:46	(Chi-Med)Hutchinson China Meditech Limited	1,680
31/7/2018	06:25	Hutchison Chi-Med (HCM) One to Watch	1
23/7/2018	09:55	Hutchison Chi-Med (HCM) One to Watch on Monday	1
13/6/2017	06:54	Hutchison China Meditech- CHARTS AND DISCUSSION	74

Add a New Thread

Hutchison China Meditech (HCM) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
18:28:25	4,850.00	14	679.00	O
17:46:28	4,769.52	83	3,958.70	O
17:05:36	4,769.79	21	1,001.65	O
16:37:52	4,850.00	3	145.50	O
16:35:26	4,850.00	250	12,125.00	UT

View all Hutchison China Meditech trades in real-time

Hutchison China Meditech (HCM) Top Chat Posts

Date	Subject
12/11/2018 08:20	Hutchison China Meditech Daily Update: Hutchison China Meditech is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchison China Meditech was 4,820p. Hutchison China Meditech has a 4 week average price of 4,400p and a 12 week average price of 4,225p. The 1 year high share price is 5,920p while the 1 year low share price is currently 3,985p. There are currently 66,532,683 shares in issue and the average daily traded volume is 14,242 shares. The market capitalisation of Hutchison China Meditech is £3,226,835,125.50. Read Full Thread Reply
01/11/2018 07:19	nerdofsteel: Volume always seems to increase significantly prior to significant pipeline news.....apart from Fruquintinib approval where absolutely nothing happened with regard to the share price! Read Full Thread Follow Reply
14/9/2018 19:55	sportii: Chi-med share price has not been moving in the positive direction, even after the major news of first drug approval. Due to the unfortunate geopolitical situation, institutional buyers in the USA are not showing any interest. Hence, share price is suffering and we, long time holders, are disappointed. Unless, there are new buyers who are willing to buy, share price will not move up. That will be the case even if the company gets approval for two or more drug candidates. Wondering why the management isn’t interested in listing on HK stock exchange. Read Full Thread Follow Reply
07/9/2018 07:34	sportii: Any early falls in the share price going to bevtransient. Expecting ‘corrections’ by this afternoon. Read Full Thread Follow Reply
07/9/2018 06:51	reptile3: kazoom.... I should have said with reference to the drop on Nasdaq where at 8.30p.m. UK time the share price was 9.3% down on the day and therefore anticipating the drop to around £41 on AIM. Read Full Thread Follow Reply
06/9/2018 17:59	sportii: Everything else, other than the share price, appears positive. Big drop in share price on the other side of the pond, today. Is yesterdsy’s approval news not good enough for the big buyers? Disheartened sellers, perhaps. Read Full Thread Follow Reply
01/8/2018 11:31	lauders: The sudden weakness is probably a combination of two things: 1) The vaccine issue that is rocking China: https://www.bloomberg.com/news/articles/2018-08-01/vaccine-scare-has-china-moving-to-contain-consumer-backlash 2) The likelihood of no news for a few months post the results release. May be time to top-up if the fall becomes overdone. Seems that the US dictates the share price direction these days. Read Full Thread Follow Reply
31/7/2018 08:31	nimrod22: should be seen as a buying opportunity while the share price is slopping around at low volume. Read Full Thread Follow Reply
15/7/2018 09:35	nimrod22: I did wonder if the share price may have suffered because it has "China" in the company name and the frequent news about tariffs?? For anybody following Chinese based shares.. Xiaomi on the Hong Kong board is worth a punt, IPO last Monday at low end of valuation of 17HK$, dropped and since recovered to 21.45HK$. Will also be listed on the Hang Seng index on 23rd July. Plenty of info out there. Read Full Thread Follow Reply
15/3/2018 16:43	dbadvn: Had a very interesting meeting with the CFO . They are certainly sticking to plan and gearing up for European/US sales independently of whatever happens with Lilley etc. Making all the right noises on Clinical/ Sales teams/ Branding/ Competition and realistic on timescale. Not defending the fact that the recent cash raise was basically opportunistic use of perfect market conditions . Looking to be cash flow positive within 5 years ( doe not exclude more cash raising depending on opportunities). The positive "elephant in the room" is the $50bn potential of HMPL 523 in the immunology market. Although still at the early stages HCM seem to have the lead here and only Gilead as competition. Short term lack of news flow may see the share price drift but medium and long term potential probabilities of success are increasing . At some point the US market will start to valur HCM in the same way as the US Biotechs ( less the takeover premium perhaps ) .At that point the share price will react strongly . When that happens is anyones guess so I for one am staying invested long term Read Full Thread Follow Reply
15/3/2018 14:03	nerdofsteel: mad - agree 100%, and if you look back at the share price in London over the last 10 years you see sometimes quite lengthy periods where the share price is stagnant, followed by sharp increases, then further stagnation Read Full Thread Follow Reply

Hutchison China Meditech share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:40 V: D:20181112 19:51:35